From July 20, 2023 to September 8, 2023, the company has repurchased 5,323,451 shares, representing 21.86% for $3.73 million. With this, the company has completed the repurchase of 5,323,451 shares, representing 21.86% for $3.73 million under the buyback announced on July 20, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.95 USD | -9.50% | -2.52% | -6.08% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.08% | 8.01M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Tranche Update on Pasithea Therapeutics Corp.'s Equity Buyback Plan announced on July 20, 2023.